Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay.
Murat BuyuktepeIbrahim KaplanEyup BayatliHaldun DoganHasan Caglar UgurPublished in: Journal of neuro-oncology (2023)
Our outcomes support the prognostic value of MGMT promoter methylation in patients with high grade glioma. Sequencing of whole promoter CpG islands demonstrated that methylation of particular CpG sites might predict clinical outcomes more precisely.